Skip to main content
NCBI home page
Canadian Journal of Public Health = Revue Canadienne de Santé Publique logoLink to Canadian Journal of Public Health = Revue Canadienne de Santé Publique
editorial
. 2002 Mar 1;93(2):85–87. doi: 10.1007/BF03404543

Tuberculosis in Immigrants to Canada

A Global Problem Which Requires a Global Solution

La tuberculose chez les immigrants au Canada

Robert L Cowie 11,✉, Stephen K Field 11, Donald A Enarson 21
PMCID: PMC6979999  PMID: 11963525

The content is available as a PDF (163.5 KB).

References/Références

  • 1.Rieder HL. Epidemiologic Basis of Tuberculosis Control. Paris: IUATLD; 1999. [Google Scholar]
  • 2.Dye C, Scheele S, Dolin P, Pathania V, Raviglione MC. Global burden of tuberculosis. Estimated incidence, Prevalence, And mortality by country. JAMA. 1999;282:677–86. doi: 10.1001/jama.282.7.677. [DOI] [PubMed] [Google Scholar]
  • 3.Grange JM. Paradox of the global emergency of tuberculosis. Lancet. 1999;353:996. doi: 10.1016/S0140-6736(99)01196-4. [DOI] [PubMed] [Google Scholar]
  • 4.Cowie RL, Langton ME, Becklake MR. Pulmonary tuberculosis in South African gold miners. Am Rev Respir Dis. 1989;139:1086–89. doi: 10.1164/ajrccm/139.5.1086. [DOI] [PubMed] [Google Scholar]
  • 5.East African/British Medical Research Council. Controlled clinical trial of four short-course regimens of chemotherapy for two durations in the treatment of pulmonary tuberculosis. Am Rev Respir Dis. 1978;118:39–48. doi: 10.1164/arrd.1978.118.1.39. [DOI] [PubMed] [Google Scholar]
  • 6.Medical Research Council. Streptomycin treatment of pulmonary tuberculosis. BMJ. 1948;ii:769–83. [Google Scholar]
  • 7.Mitchison DA. Drug resistance in mycobacteria. Br Med Bull. 1984;40:84–90. doi: 10.1093/oxfordjournals.bmb.a071952. [DOI] [PubMed] [Google Scholar]
  • 8.Long R, Njoo H, Hershfield E. Tuberculosis: 3. Epidemiology of the disease in Canada. CMAJ. 1999;160:1185–90. [PMC free article] [PubMed] [Google Scholar]
  • 9.Cowie RL, Sharpe JW. Tuberculosis among immigrants: Interval from arrival in Canada to diagnosis. A 5-year study in southern Alberta. CMAJ. 1998;158:599–602. [PMC free article] [PubMed] [Google Scholar]
  • 10.Manns BJ, Fanning EA, Cowie RL. Antituberculosis drug resistance in immigrants to Alberta, Canada, With tuberculosis, 1982–1994. Int J Tuberc Lung Dis. 1997;1:225–30. [PubMed] [Google Scholar]
  • 11.Long R, Fanning A, Cowie R, Hoeppner V, Fitzgerald M. Antituberculous drug resistance in western Canada (1993 to 1994) Can Respir J. 1997;4:71–76. doi: 10.1155/1997/169521. [DOI] [Google Scholar]
  • 12.Mitchison DA, Nunn AJ. Influence of initial drug resistance on the response to short-course chemotherapy of pulmonary tuberculosis. Am Rev Respir Dis. 1986;133:423–30. doi: 10.1164/arrd.1986.133.3.423. [DOI] [PubMed] [Google Scholar]
  • 13.Uppaluri A, Naus M, Heywood N, Brunton J, Kerbel D, Wobeser W. Effectiveness of the immigration medical surveillance program for tuberculosis in Ontario. Can J Public Health. 2002;93(2):88–91. doi: 10.1007/BF03404544. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 14.Nolan CM, Aitken ML, Elarth AM, Anderson KM, Miller WT. Active tuberculosis after isoniazid chemoprophylaxis of Southeast Asian refugees. Am Rev Respir Dis. 1986;133:431–35. doi: 10.1164/arrd.1986.133.3.431. [DOI] [PubMed] [Google Scholar]
  • 15.Long R, editor. Canadian Tuberculosis Standards. 5th ed. 2000. [DOI] [PubMed] [Google Scholar]
  • 16.Kopanoff DE, Snider DE, Caras GJ. Isoniazidrelated hepatitis. Am Rev Respir Dis. 1978;117:991–1001. doi: 10.1164/arrd.1978.117.6.991. [DOI] [PubMed] [Google Scholar]
  • 17.Snider DE, Caras GJ. Isoniazid-associated hepatitis deaths: A review of the available information. Am Rev Respir Dis. 1992;145:494–97. doi: 10.1164/ajrccm/145.2_Pt_1.494. [DOI] [PubMed] [Google Scholar]
  • 18.Turner MO, Elwood RK. Severe hepatic complications of antituberculous therapy. Can J Infect Dis. 1999;10:167–69. doi: 10.1155/1999/342613. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 19.Centers for Disease ControlPrevention. Update: Fatalsevere liver injuries associated with rifampinpyrazinamide for latent tuberculosis infection,revisions in American Thoracic Society/CDC recommendations — United States, 2001. Am J Respir Crit Care Med. 2001;164:1319–29. doi: 10.1164/ajrccm.164.7.16471. [DOI] [Google Scholar]
  • 20.Enarson DA. Screening for tuberculosis infection and disease. Monaldi Arch Chest Dis. 1998;53:144–47. [PubMed] [Google Scholar]
  • 21.Comstock GW, Edwards PQ. The competing risks of tuberculosis and hepatitis for adult tuberculin reactors. Am Rev Respir Dis. 1975;111:573–77. doi: 10.1164/arrd.1975.111.5.573. [DOI] [PubMed] [Google Scholar]
  • 22.Schwartzman K, Menzies D. Tuberculosis screening of immigrants to low-prevalence countries. Am J Respir Crit Care Med. 2000;161:780–89. doi: 10.1164/ajrccm.161.3.9902005. [DOI] [PubMed] [Google Scholar]
  • 23.Zuber PL, McKenna MT, Binkin NJ, Onorato IM, Castro KG. Long-term risk of tuberculosis among foreign-born persons in the United States. JAMA. 1997;278:304–7. doi: 10.1001/jama.1997.03550040060038. [DOI] [PubMed] [Google Scholar]
  • 24.Zumla A, Grange JM. Establishing a united front against the injustice of tuberculosis. Int J Tuberc Lung Dis. 1998;2:179–81. [PubMed] [Google Scholar]
  • 25.Benatar SR. Respiratory health in a globalizing world. Am J Respir Crit Care Med. 2001;163:1064–67. doi: 10.1164/ajrccm.163.5.16354. [DOI] [PubMed] [Google Scholar]
  • 26.Declaration of Alma-Ata. International Conference on Primary Health Care, 6–12 September 1978, Alma-Ata, USSR. World Health Organisation, Geneva.’

Articles from Canadian Journal of Public Health = Revue Canadienne de Santé Publique are provided here courtesy of Springer

RESOURCES